Bulletin
Investor Alert

New York Markets Open in:

AstraZeneca PLC

LON: UK:AZN

GO
/marketstate/country/uk

Market open

AZN
/zigman2/quotes/203048482/delayed

7,395.00

p

Change

-51.00 -0.68%

Volume

Volume 1.61m

Feb 25, 2020, 1:35 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/203048482/delayed

Previous close

7,446.00 p

7,395.00 p

Change

-51.00 -0.68%

Day low

Day high

7,356p

7,452p

Open
Open: 7,419.00

52 week low

52 week high

5,626p

7,948p

Open

Market cap

£97.71B

Average volume

1.95M

P/E ratio

91.69

Rev. per Employee

N/A

EPS

0.81

Dividend

71.90

Div yield

2.95%

Ex dividend date

8/8/19

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/uk/azn

MarketWatch News on AZN

  1. U.K. stocks snap three-day losing run

    11:46 a.m. Sept. 19, 2019

    - Steve Goldstein

  2. London markets fall as Italy worries spread

    5:20 a.m. May 28, 2019

    - Dave Morris

  3. Italian stocks send Europe screeching into reverse

    5:16 a.m. May 28, 2019

    - Dave Morris

  4. Loading more headlines...
/news/nonmarketwatch/company/uk/azn

Other News on AZN

  1. Roche’s Immunotherapy Drug Extended Patients’ Lives

    9:20 p.m. Dec. 7, 2017

    - The Wall Street Journal Interactive Edition

  2. In U.K., Barriers Rising Against Foreign Deals

    9:28 a.m. May 11, 2015

    - The Wall Street Journal Interactive Edition

  3. Celgene Profit Surges, Driven by Revlimid Sales

    7:18 a.m. April 30, 2015

    - The Wall Street Journal Interactive Edition

  4. AstraZeneca Reports Fall in First-Quarter Profit

    7:26 a.m. April 24, 2015

    - The Wall Street Journal Interactive Edition

  5. Billion-Dollar Health Startups

    4:21 p.m. Feb. 27, 2015

    - The Wall Street Journal Interactive Edition

  6. Valeant to Buy Salix for About $10 Billion

    8:44 p.m. Feb. 23, 2015

    - The Wall Street Journal Interactive Edition

  7. New Cancer Technology Cheers Investors

    3:35 p.m. Feb. 23, 2015

    - The Wall Street Journal Interactive Edition

  8. Valeant Nears Deal to Buy Salix

    1:58 p.m. Feb. 22, 2015

    - The Wall Street Journal Interactive Edition

  9. Actavis Changing Name to Allergan

    11:24 a.m. Feb. 18, 2015

    - The Wall Street Journal Interactive Edition

  10. Pharma Must Launch Itself Back

    7:17 p.m. Feb. 16, 2015

    - The Wall Street Journal Interactive Edition

  11. Corporate Watch: News Digest

    11:42 p.m. Feb. 5, 2015

    - The Wall Street Journal Interactive Edition

  12. AstraZeneca Deals Up a Tricky 2015

    11:55 a.m. Feb. 5, 2015

    - The Wall Street Journal Interactive Edition

  13. Pfizer to Buy Hospira for $16 Billion

    10:22 a.m. Feb. 6, 2015

    - The Wall Street Journal Interactive Edition

  14. Astra to Buy Actavis Portfolio

    6:54 a.m. Feb. 5, 2015

    - The Wall Street Journal Interactive Edition

  15. New Outsourcing Frontier in India: Monitoring Drug Safety

    10:20 p.m. Feb. 2, 2015

    - The Wall Street Journal Interactive Edition

  16. AstraZeneca to Harness Benefits of Genome-Editing Technology

    6:06 a.m. Jan. 29, 2015

    - The Wall Street Journal Interactive Edition

  17. Pfizer Sales Hit by Stronger Dollar

    9:53 p.m. Jan. 27, 2015

    - The Wall Street Journal Interactive Edition

  18. Teva: FDA Approves Generic Version of AstraZeneca Heartburn Drug

    5:07 p.m. Jan. 26, 2015

    - The Wall Street Journal Interactive Edition

  19. Peter Wallenberg Dies at 88

    3:26 p.m. Jan. 19, 2015

    - The Wall Street Journal Interactive Edition

  20. Pharma Grows Itself a New Challenge -- Overheard

    6:51 p.m. Jan. 13, 2015

    - The Wall Street Journal Interactive Edition

  21. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.